Crispr Therapeutics Ag (CRSP)

Operating Cash Flow Growth

-13.80%

TTM · Period ending:

CRSP logo

CRSP Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-13.80%
CRSP TTM Cash from Operations YoY % (-193.07% → -13.80%)
High-resolution chart · PNG

CRSP operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crispr Therapeutics Ag Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-13.7977%
-30.5055%
-141.6504%
-60.2046%
-166.7326%
-92.2401%
45.166%
31.9901%
64.5009%
54.6714%
47.4776%
40.7345%
22.8472%
-169.7276%
-191.979%
-186.1443%
-180.9138%
275.8372%
326.1111%
453.6254%
892.7849%
-694.6516%
-520.5692%
-716.8639%
143.0828%
141.1287%
158.8919%
130.1406%
-63.4017%
-69.0687%
-37.294%
-10.7646%
-10.5995%
-0.9679%
-26.7348%
-325.524%
-277.3738%
-234.7295%
-193.0706%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.